Secondary Recommendation

Medica - Hot telehealth new issue

April 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Medica (MGP; 190p) had a superb opening pop on its debut to the Full List. The company, which offers an outsourced radiography service for hospitals, has got investors in a frenzy because the business is at the forefront of the telehealth revolution, where healthcare services are being delivered remotely using digital telecommunications technology. We might be familiar with the diagnostic radiographers working in the radiology or imaging departments of hospitals. Using the latest technology such as computed tomography (CT), ultrasound, plain film X-ray or magnetic resonance imaging (MRI), their key role is to produce detailed images that can be used by the consultant to diagnose injury or disease. In recent years there ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Luceco - High flying LED business

IG Design - To exceed market forecasts

Medica - Bid at 212p (May 2023)

Medica - Moves into US$1bn US clinical trials market (May 2021)

Medica (November 2020)

Medica Group (August 2020)

Medica (September 2018)

Medica - Radiology recruitment jumps in Q2 (May 2018)

Medica (February 2018)

Medica (November 2017)

Medica - Sets up advanced practitioner radiography network alongside radiologist one (May 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X